Review of etoposide.
D000818:Animals; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D055598:Chemical Phenomena; D002621:Chemistry; D002945:Cisplatin / Q000494:pharmacology; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D004357:Drug Synergism; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008297:Male; D051379:Mice; D011034:Podophyllotoxin / Q000031:analogs & derivatives; D051381:Rats; D013736:Testicular Neoplasms / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D005047:Etoposide; D011034:Podophyllotoxin; D002945:Cisplatin